Posted on May 8th, 2012 by daniel
Steven Cohen’s SAC Capital Advisors released two new 13G filings today disclosing a new position in Zillow (Z) and additional holdings in Sequenom (SQNM). SAC Capital now holds 1,011,501 shares (5%)of Zillow as of May 7th and 6,128,919 shares (5.4%) of SQNM as of May 7th. The SQNM holdings is an increase of 6,096,154 shares […]
Posted on May 8th, 2012 by daniel
From a recently disclosed 13G filing it was revealed that J. Carlo Cannell has reduced his holdings in SUNH to 1,213,745 shares. The transaction took place on March 23rd. This is down 381,759 shares from what was reported as recently as 2/13/2012, but Cannell still retains a 4.8% stake in the company. From Yahoo Finance, […]
Posted on May 4th, 2012 by daniel
Daniel Loeb’s hedge fund Third Point has filed a Schedule 13G revealing that the fund has sold out of XRM. Third Point had held 1,700,000 shares as recently as 12/31/2011. The final transaction took place on May 2nd. Steven Cohen’s SAC Capital Advisors has filed a 13G disclosing ownership of 3,143,160 shares of WLT as […]
Posted on May 4th, 2012 by daniel
Scoggin Capital Management released a new 13G disclosing a 1,999,000 share position in OAK. This gives Scoggin a 6.5% stake in OAK and comes a day after David Einhorn’s Greenlight Capital revealed a similar 1,679,750 share (5.5%) stake in OAK. Scoggin’s transaction took place on April 12th, the day of OAK’s IPO (why so long […]
Posted on May 3rd, 2012 by daniel
Steven Cohen’s SAC Capital Advisors has released a Schedule 13G disclosing a new position in SNTS as of May 2nd. SAC Capital reports owning 3,231,392 shares giving them a 5.2% stake in SNTS. Santarus, Inc. is a specialty biopharmaceutical company engaging in the acquiring, developing, and commercializing of proprietary products that address the needs of patients treated by […]